Raymond James Financial Services Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,252
| Closed | -$215K | – | 3259 |
|
|
2021
Q3 | $215K | Hold |
4,252
| – | – | ﹤0.01% | 2922 |
|
|
2021
Q2 | $334K | Sell |
4,252
-80
| -2% | -$6.28K | ﹤0.01% | 2643 |
|
|
2021
Q1 | $247K | Sell |
4,332
-400
| -8% | -$22.8K | ﹤0.01% | 2754 |
|
|
2020
Q4 | $396K | Buy |
+4,732
| New | +$396K | ﹤0.01% | 2283 |
|
|
2019
Q2 | – | Sell |
-9,588
| Closed | -$223K | – | 2810 |
|
|
2019
Q1 | $223K | Sell |
9,588
-475
| -5% | -$11K | ﹤0.01% | 2429 |
|
|
2018
Q4 | $208K | Sell |
10,063
-10,390
| -51% | -$215K | ﹤0.01% | 2236 |
|
|
2018
Q3 | $445K | Buy |
20,453
+2,200
| +12% | +$47.9K | ﹤0.01% | 2005 |
|
|
2018
Q2 | $278K | Buy |
+18,253
| New | +$278K | ﹤0.01% | 2285 |
|